Recalls of prescription, OTC drugs increase from 2008 to 2009.
CNNMoney.com (8/17, Kavilanz) reports, "Recalls of prescription and over the counter drugs are surging, raising questions about the quality of drug manufacturing in the United States." The FDA "reported more than 1,742 recalls last year, skyrocketing from 426 in 2008, according to the Gold Sheet, a trade publication on drug quality that analyzes FDA data," although the drug repackager Advantage Dose "accounted for more than 1,000 of those recalls." CNN also notes that two "bills introduced this year would impose stricter regulations on the industry, and give the FDA authority to mandate recalls."